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Modulation of Rat Skeletal Muscle Branched-Chain
a-Keto Acid Dehydrogenase In Vivo
Effects of Dietary Protein and Meal Consumption
Kevin P. Block, R. Paul Aftring, William B. Mehard, and Maria G. Buse

Departments of Medicine and Biochemistry, Medical University of South Carolina, Charleston, South Carolina 29425

Abstract
The effects of dietary protein on the activity of skeletal muscle
branched-chain a-keto acid dehydrogenase (BCKAD) were investigated. BCKAD is rate-limiting for branched-chain amino
acid (BCAA) catabolism by muscle; its activity is modulated by
phosphorylation-dephosphorylation. In rats fed an adequate
protein (25% casein) diet, BCKAD was 2% active postabsorptively and increased to 10% or 16% active after a 25% or
50% protein meal, respectively. Prolonged feeding of a 50% protein diet increased postabsorptive BCKAD activity to 7% with
further increases to 40% active postprandially. On a low protein
(9% casein) diet BCKAD remained 2% active regardless of
meal-feeding. Dose-dependent activation of BCKAD by intravenous leucine in postabsorptive rats was blunted by a low protein
diet. We conclude that excesses of dietary protein enhance the
capacity of skeletal muscle to oxidize BCAA, muscle conserves
BCAA when protein intake is inadequate, and skeletal muscle
may play an important role in whole-body BCAA homeostasis.
-

-

Introduction
Chronic consumption of high protein diets results in induction
of rate-limiting degrading enzymes for most essential amino acids
(1, 2). Hence, the concentrations of most amino acids do not
increase markedly in body fluids after long-term high protein
feeding and may actually decrease as more protein is consumed
(3). When dietary protein intake is restricted to less than the
requirement for growth and maintenance these enzymes decrease
(1, 2), resulting in conservation of essential amino acids. The
catabolic system for the branched-chain amino acids (BCAA)'leucine, isoleucine, and valine-appears to be an exception to
this homeostatic scheme for essential amino acids in that (a)
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their concentrations in blood and tissues rise in direct proportion
to the protein content of the diet (3-5), and (b) BCAA aminotransferase, the initial enzyme in BCAA catabolism, is relatively
refractory to changes in dietary protein (6). This apparent lack
of adaptation has prompted some investigators to conclude that
the body is unable to maintain the free body pools of BCAA by
increasing oxidation during times of surfeit or by decreasing
oxidation during times of deficiency. However, studies in man
and rat have shown that BCAA oxidation in vivo is increased
markedly after high protein feeding (5, 7, 8) and is severely depressed after consumption oflow protein diets (5, 7). The mechanisms responsible for these alterations in BCAA oxidation are
incompletely understood. Recent studies suggest that fluctuations
in BCAA oxidation with dietary manipulations cannot be explained based solely on the mass action principle (9). Control
of BCAA metabolism by dietary protein is of particular interest,
as branched-chain amino and keto acids are being used in the
treatment of hepatic encephalopathy and renal insufficiency,
conditions in which low protein diets are usually indicated
(10, 11).
The first committed reaction in the metabolism of BCAA is
catalyzed by branched-chain a-keto acid dehydrogenase
(BCKAD), a multienzyme complex located on the inner surface
of the inner mitochondrial membrane of most cells (12, 13).
BCKAD catalyzes the irreversible oxidative decarboxylation of
branched-chain a-keto acids (BCKA)-a-ketoisocaproate (ketoleucine), a-keto-f3-methylvalerate (ketoisoleucine), and a-ketoisovalerate (ketovaline)-that are formed from their respective
BCAA through the action of BCAA aminotransferase. Both
BCKAD and BCAA aminotransferase are distributed ubiquitously but nonuniformly throughout the body. BCKAD activity
is highest in liver, kidney, and heart, but very low in skeletal
muscle (12, 13). In contrast, BCAA aminotransferase activity is
highest in skeletal muscle but very low in liver (12, 13). BCKAD
is believed to limit the rate of BCAA catabolism in vivo (14).
BCKAD is unusual among amino acid-degrading enzymes
in that it is regulated by a phosphorylation (inactivation)-dephosphorylation (activation) mechanism similar to that which
exists for the pyruvate dehydrogenase complex (12, 15). As with
pyruvate dehydrogenase, a protein phosphatase and kinase are
believed to be associated with BCKAD in vivo. Alteration of
the phosphorylation state of BCKAD permits rapid changes in
enzyme activity that are not possible via an induction-repression
mechanism (13). The physiological significance of BCKAD
modulation by phosphorylation is currently an active area of
study (16).
In normally fed rats, BCKAD from liver is essentially fully
active (i.e., dephosphorylated) (13, 17-19). In contrast, < 20%
of skeletal muscle BCKAD is in the active form (12, 13, 18, 20,
21). As skeletal muscle comprises 40% of the rat's body weight
(22), changes in the phosphorylation state of muscle BCKAD
-
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could have profound effects on BCAA metabolism in vivo.
However, efforts to detect changes in the activity state of muscle
BCKAD in response to physiological manipulations have been
largely unsuccessful (13, 20, 23). In view of the high BCAA
aminotransferase and low BCKAD activity of muscles, it was
proposed that muscle may primarily deaminate BCAA and release BCKA into the circulation for eventual oxidation by liver
where BCKAD is found in abundance (12, 13, 24). Uncertainty
about the role of muscle in BCAA metabolism has stemmed in
part from the difficulty in measuring activities of BCKAD from
solubilized muscle preparations (20, 25-27). Therefore, intact
muscle mitochondria were used in most studies to assay BCKAD
activity (13, 18, 23, 26). Problems associated with substrate
transport, quantitation of precursor-specific radioactivity, and
possible activation of the enzyme during mitochondrial isolation
or incubation complicate interpretation of such studies. Recently,
we described an assay for measuring BCKAD in solubilized rat
muscle tissue and showed that the enzyme was activated in vivo
after intravenous leucine administration (21). We have used this
assay in the present study and found that muscle BCKAD is
activated rapidly in vivo after consumption of meals containing
adequate-to-high levels of protein, and that the activation state
of the enzyme is responsive both acutely and chronically to the
protein content of the diet.

Methods
Animals. Male Wistar (WI) BR rats (Charles River Laboratories, Wilmington, MA), initially weighing 140-160 g, were used in all studies.
Rats were kept in a room maintained at 240C with a reverse 12-h-light12-h-dark cycle. The dark period was from 3:00 a.m. to 3:00 p.m. Rats
were offered their daily allotment of food within the last 6 h of the dark
cycle (9:00 a.m.-3:00 p.m.). This meal-feeding regimen minimized variations in enzyme and metabolite measurements due to fluctuations in
food intake (3). Water was supplied ad libitum.
Diets and treatments. All diets were specially prepared in pellet form
by United States Biochemical Corp., Cleveland, OH, and contained in
percentage by weight: Rogers and Harper's mineral mix, 5 (28); AIN 76
vitamin mix, 1; corn oil, 5; choline chloride, 0.2; vitamin-free casein, 0,
9, 25, or 50; and equal amounts of glucose monohydrate (A. E. Staley
Manufacturing Co., Oak Brook, IL) and cornstarch (American Maize,
Hammond, IN) to make up 100%. The 9% casein diet was supplemented
with methionine, 0.3% (wt/wt) (29). Rats were acclimated to the 25%
casein diet ad libitum for 2 d, then trained to consume the 25% casein
diet during the last 6 h of the dark cycle for 2 wk (meal-feeding). After
this training period, both chronic and acute effects of dietary protein on
BCAA metabolism were studied. In the chronic study, rats were mealfed the 0, 9, 25, or 50% casein diets for 10 d. Body weights were measured
each day. On the 10th day, rats were killed before or 3 h after presentation
of the meal. Previous studies have shown that circulating levels of BCAA
are greatest 3 h postprandially in meal-fed rats (29). In the acute studies,
rats previously fed the 25% casein diet for 2 wk were offered a single
meal containing 9, 25, or 50% casein. Rats failed to consume a single
meal of the 0% casein diet, hence this group was omitted. Rats were
killed before and 3, 6, and 12 h after presentation of the meal.
Previous studies (3, 29, 30) have shown that during the first few days
of offering an adequate protein diet for 6-8 h/d (meal-feeding), food
consumption is less than that of ad libitum-fed rats. However, food
intake increases gradually and after I wk, meal-fed and ad libitum-fed
rats consume equal amounts of food. Rats maintained chronically on
casein diets similar to those used here consume equal amounts of food
except for those given a protein-free diet, which consume 43% less (30).
In the present study, food intake was measured in the acute experiments
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and was not significantly different between rats fed 9,25, or 50% casein
diets (14±1 g/meal).
In a separate experiment, the effects of leucine infusions on muscle
BCKAD activity were investigated in rats fed 25 or 9% casein diets ad
libitum for 2 wk. Rats were anesthetized with methoxyflurane (Metofane)
after an overnight fast (21) and L-leucine was infused via the tail vein
at doses of 0, 10, 25, 50, and 100 Mmol/100 g body weight. Muscles were
excised 15 min after injections.
BCKAD assay. Our method for determining BCKAD activity in
muscle has been described in detail previously (21,31). Briefly, the method
involved freeze-clamping whole muscle in situ. BCKAD was extracted
from powdered frozen muscle in the presence of protease, phosphatase,
and kinase inhibitors and then precipitated with polyethylene glycol.
Basal (in vivo) BCKAD activities were determined immediately after
redissolving the precipitated proteins, and total (fully active) enzyme
activities were measured after preincubation of the extract at 370C with
15 mM Mg2e before assay. In these studies BCKAD activity was determined by "CO2 release from 0.1 mM a-keto[-I"C`isovalerate at 370C.
Percentage of BCKAD in the active form was calculated as the ratio of
basal to total BCKAD activities.
Amino acids, protein, and DNA. Heparinized plasma was deproteinized by adding ice cold sulfosalicylic acid (0.1 vol of a 50% wt/vol solution). After standing 20 min on ice, samples were centrifuged at 30,000
g for 10 min. Muscle samples were deproteinized by adding 4 vol of ice
cold 5.9% wt/vol sulfosalicylic acid to powdered muscle samples. Muscles
were then homogenized with a Polytron tissue homogenizer and left on
ice for 20 min. The mixture was then centrifuged at 30,000 g at 4°C for
10 min. Plasma and muscle BCAA concentrations in deproteinized samples were measured using reversed-phase high performance liquid chromatography separation of the o-phthalaldehyde derivatives and fluorescent detection (32). BCAA concentrations (;&mol/g) were expressed per
milliliter of intracellular water assuming that muscle contains 80% water:
60% intracellular and 20% extracellular, the latter at equilibrium with
plasma (33).
Muscle protein concentrations were determined according to the
method of Lowry (34) with bovine serum albumin asthe standard. Muscle
DNA concentrations were measured using a modification of the Burton
assay (35) with herring sperm DNA as the standard.
Statistical analyses of differences between groups were performed by
Student's t test or by the Peritz multiple range F test (36) and were
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Figure 1. Linearity of basal muscle BCKAD from rats fed differing
levels of protein. Rats were meal-fed diets containing 0, 25, or 50% casein for 2 wk. Muscles were frozen in situ after 3 h of feeding. Basal
BCKAD activity was measured for 1, 2, or 5 min using 150 #1 of enzyme extract, as described in Methods. Values represent means±SEM
for enzyme activities from 4 rats per diet group. Identical values were
obtained when 100 jul of enzyme extract was used (data not shown).
-
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Figure 2. Effect of preincubation time on activation of muscle
BCKAD isolated from rats fed differing levels of protein. Rats were
treated as described in Fig. 1. Total BCKAD activity was measured as
described in Methods. Enzyme activities were measured after 20, 40,
60, or 80 min preincubation with 15 mM Mg2+. Values represent
means+SEM for enzyme activities from 3-4 rats per diet group.

considered significant if P < 0.05. Values for percent active complex
were subjected to the inverse sine transformation before statistical analysis
as percentages are distributed binomially rather than normally (37). This
transformation is especially recommended for values in the range of
most of the present observations (0-20%). Regression analysis was performed by the linear least squares method and slopes compared by Student's t test (37). All values shown are means±SEM.

Results
BCKAD assay. As others have shown diet-mediated changes in
BCKAD activities from liver, kidney, and heart (12, 13, 17, 19,
20), we first sought to optimize the assay for BCKAD isolated
from muscles of rats fed diffiering levels of protein. Rats were
meal-fed 0,25 (normal), or 50% (high) casein diets for 2 wk.

Muscles were excised 3 h after presentation of the meal. As shown
in Fig. 1, basal (in vivo) BCKAD activity increased as the protein
content of the diet increased. The assay for basal BCKAD activity
was linear up to 5 min in all diet groups, whether 100 or 150 41
of muscle extract was used. To ensure that no more than 10%
of a-ketoisovalerate was utilized during the reaction (38), basal
activities from 0 and 9% casein groups were routinely assayed
for 5 min with 150 ul of extract. Basal BCKAD activities from
25 and 50% casein groups were assayed for 2-5 min with 100
,ul of extract. Total BCKAD activities were linear up to 3 min
in all diet groups; therefore, total activities were routinely assayed
over 1 min (21, 31).
Recently, Randle and associates have shown that BCKAD
from liver of rats fed low protein diets is refractory to dephosphorylation (39). To investigate whether dietary protein might
affect the rate of muscle BCKAD activation, total BCKAD activities were measured 20, 40, 60, and 80 min after preincubation
at 37°C in a buffer containing 15 mM Mg2e. The time required
to attain maximal BCKAD activities in muscle extracts from
rats fed diets containing 0, 25, or 50% casein are shown in Fig.
2. Maximal activities for rats fed the 25 or 50% casein diets were
obtained after 40 min of preincubation. In contrast, maximal
BCKAD activities in muscles of rats fed the 0% casein diet were
not obtained until 60 min of preincubation. This lag phase of
muscle BCKAD activation was also observed in rats fed the 9%
casein diet (data not shown). Fully activated (total) enzyme activities (nmol/min per g tissue) were not significantly different
among the groups.
Chronic effects of dietary protein. Rats fed the protein-free
diet failed to thrive and lost 40 g of weight during the 10-d
study (Table I). Addition of 9, 25, or 50% casein to the diet
resulted in growth rates of 4-6 g/d. Rats fed the 9% casein diet
attained 60% of the weight gain observed in rats fed the 25%
casein diet. Continued growth on the 9% casein diet was most
probably due to its supplementation with methionine, the first
limiting amino acid in casein; hence this diet constituted a protein
restricted rather than an essential amino acid deficient diet. The
changes in growth due to dietary protein were accompanied by
alterations in the protein and DNA concentrations in skeletal
muscle (Table I). The protein/DNA ratio, a measure of cell size,
was significantly depressed when protein was omitted from the
-

Table I. Effects of Dietary Protein on Total Muscle BCKAD Activities Expressed on a Wet Weight, Protein, or DNA Basis
Total BCKAD activity
Casein

Body weight change

DNA

Protein

Tissue

DNA

Protein

%

g1O d

Ug/g

mg/g

nmol/min/g

nmol/min/mg

nmol/min/g

0
9
25

-41+2*

537±16*

174±7*

64±5*

+40±4*

448±15*

188±12**

63±6*

120±10*
140±9*

+64±2§
+59±2§

466±13*
432±16t

222±11*
200±1O**

63±5*
78±4*

368±23*$
332±14*$
304+35*
406±35*

50

135±14*

185±15*

Rats were trained to meal-feeding on a 25% casein diet as described in Methods, then changed to diets with varying casein content as shown for a
period of 10 d. Starting weights were not significantly different among rats fed the four diets (205±1 g; n = 64). DNA, protein, and total BCKAD
activities expressed per gram of tissue were unaltered 3 h after feeding. Therefore, postabsorptive and postprandial values for each diet group were
pooled. Numbers represent means±SEM for n = 13 (0% casein), 15 (9 and 50% casein), or 21 (25% casein) rats/group. DNA, protein, and total
BCKAD activities were measured as described in Methods. Values in vertical columns with different superscript symbols are significantly different
(P < 0.05).
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Figure 3. Chronic effects of dietary protein on the percentage of active muscle BCKAD and plasma concentration of leucine. Rats were meal-fed diets containing 0, 9,
25, or 50% casein for 10 d. On the 10th day, rats were

50%

killed before (open bars) or 3 h after (hatched bars) presentation of the meal. All postprandial rats had food in
their stomachs at the time of sacrifice. Muscle BCKAD
activity was measured as described in Methods and the
percent active complex (A) computed as basal (in vivo)
activity divided by total (fully active) activity X 100. Total
BCKAD activities for each diet group are given in Table
I. Plasma leucine concentrations (B) were measured as described in Methods. Before meal values represent
means±SEM for n = 5 (0, 9, 50% casein) or 11 (25% casein) rats per group. After-meal values represent
means±SEM for 8-10 rats per group. *P < 0.01 compared with before meal values.

diet (g protein/g DNA = 336±16, 418±16, 458±18, and 464±17
for rats fed 0, 9, 25, or 50% casein respectively).
The effects of consuming 0, 9, 25, or 50% casein diets for
10 d on the percentage of active BCKAD in muscle are shown
in Fig. 3 A. Measurements were made before (postabsorptive)
or 3 h after (postprandial) presentation of the meal. All postprandial rats had food in their stomachs at sacrifice. Compared
with postabsorptive values, consumption of the 0 or 9% casein
diets had no significant effect on the activity state ofthe complex.
In contrast, the activity state of BCKAD increased markedly
(approximately sevenfold) after consumption of the 25 or 50%
casein diets. The postabsorptive BCKAD activity was identical
in rats fed 9 or 25% casein; however the postprandial activity
was 80% lower in the former group. Consumption of the diet
containing 50% casein resulted in greater than threefold increases
in both postabsorptive and postprandial BCKAD activities when

compared with the group fed the normal protein diet (25% casein). The postabsorptive BCKAD activity in rats fed 50% casein
was significantly higher than the activities in the 9 and 25%
casein-fed rats. Interestingly, consumption of a protein-free diet
resulted in significantly higher postabsorptive activities than observed in the 9 and 25% casein groups.
The effects of dietary protein on total BCKAD activity (an
estimate of enzyme content) are shown in Table I. Total BCKAD
activity was not significantly different in rats fed the 25, 9, or
0% casein diets. In contrast, consumption of high levels of protein
resulted in increases in total BCKAD activity when expressed
per milligram DNA or per gram protein (Table I). Hence, the
apparent amount of BCKAD complex per muscle cell increased
35% after feeding a high protein diet for 2 wk.
We have recently demonstrated that infusions of leucine result in activation of rat muscle BCKAD (21). Therefore, plasma

-
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BCAA concentrations were measured in the present study. As
shown in Fig. 3 B, the concentration of plasma leucine increased
in direct proportion to the protein content of the diet. In general,
the increases in plasma leucine paralleled the changes in the
activation state of the complex (r = 0.78 1; n = 62; P < 0.00 1).
Similar relationships were observed between the activity state
of BCKAD and the plasma concentrations of isoleucine or valine
(r = 0.783 for both; n = 62; P < 0.001). However, a causal
relationship between these amino acids and the activity of the
complex is unlikely as we have shown previously that infusions
of equimolar amounts of valine or isoleucine fail to activate
BCKAD (21). The intracellular concentrations of leucine were
measured in muscles of some rats before and after consuming
the four diets (Table II). Intracellular leucine concentrations were
significantly correlated (r = 0.498; n = 40; P < 0.01) with the
activity of muscle BCKAD. The intracellular concentrations of
leucine increased postprandially in rats fed 9, 25, or 50% casein,
but not in rats fed the protein-free diet. The postabsorptive intracellular leucine concentrations were similar among the groups
fed 0, 9, or 25% casein diets, but were increased in the group
fed the 50% casein diet. The postprandial intracellular leucine
concentrations were significantly higher in the groups fed 25
and 50% casein than in those fed 0% casein. Meal consumption
had no significant effect on the ratio of leucine concentrations
between muscle and plasma in any of the diet groups. The highest
muscle/plasma ratios were observed in the group fed the proteinfree diet. Postprandially this ratio was significantly higher in the
0% casein group than in any of the groups fed protein containing
meals.
Acute effects of dietary protein. To examine the effects of
acute protein consumption on muscle BCKAD, rats previously
fed a 25% casein diet for 2 wk were offered a single meal of 9,
25, or 50% casein. No differences in food intake were observed
between the three groups. As shown in Fig. 4 A, consumption
of the 9% casein meal had no effect on muscle BCKAD activity
3, 6, or 12 h after feeding. In contrast, consumption of the 25
and 50% casein meals resulted in 6- and 1 -fold increases in the
percentage of active complex 3 h after presentation of the meal
(postabsorptive, 1.6±0.1% active; postprandial, 9.4±2.0 and
17.2±3.6% active, respectively). By 6 h, the proportion of
BCKAD in the active form in rats offered the 25% casein meal
returned towards baseline and changed little after 12 h. The
percentage of active complex in rats offered the 50% casein meal
decreased in a linear fashion between 3 and 12 h after presentation of the meal. By 12 h, BCKAD activity in the high protein
group was still 50% greater than baseline.
The effect of consuming single meals ofvarying protein content on the plasma concentrations of leucine is illustrated in Fig.
4 B. A strong correlation (r = 0.852; n = 45; P < 0.001) was
observed between the percentage of active BCKAD and the concentration of leucine in plasma. Significant correlations were
also observed between the activity of BCKAD and the plasma
concentrations of isoleucine (r = 0.854; n = 45; P < 0.001) and
valine (r = 0.906; n = 45; P < 0.001).
The relationship between the percentage of active BCKAD
and circulating leucine in both the chronic and acute studies is
shown in Fig. 5. Linear regression analysis between percent active
complex and plasma leucine concentration resulted in a significant direct correlation between these values (r = 0.788, n = 107,
P < 0.001). A better linear least squares fit was obtained by
semilog transformation of the data (i.e., log percent active com-

plex vs. plasma leucine concentration) which gave a correlation
coefficient of0.848 (P < 0.001). The solid line in Fig. 5 represents
the best fit line for the semilog transformation.
Leucine infusion studies. In rats fed a 9% casein diet for 10
d, consumption of the meal resulted in an approximate doubling
in plasma and intracellular leucine without a change in the activity of the complex (compare Fig. 3 A and B and Table II).
Also, the enzyme from rats fed protein-free or low-protein diets
required a longer period of incubation to attain maximal activity
(Fig. 2). To study the apparent refractoriness ofthe enzyme from
low protein-fed rats to activation, rats previously fed adequate
(25% casein) or low (9% casein) protein diets for 2 wk were
infused with varying doses of leucine (Fig. 6). BCKAD activity
was closely correlated with the dose of leucine infused (r = 0.92
for each diet group; P < 0.001) and leucine infusions at doses
of 25 gmol/ 100 g body weight or greater resulted in activation
of muscle BCKAD in both diet groups (Fig. 6 A). However, the
leucine-mediated activation of muscle BCKAD from low protein-fed rats was less than that observed in rats fed adequate
amounts of protein (P < 0.001). Plasma BCAA concentrations
were essentially identical in the two groups (Fig. 6 B and C).
Discussion
The body pools of most amino acids are enlarged in animals
immediately after they have consumed a high protein diet (13). Continued consumption of amino acids in quantities greatly
in excess of requirements would result in death if no homeostatic
controls were present. The relatively high Michaelis constants
of amino acid-degrading enzymes enable the rate of oxidation
of surplus amino acids to increase initially as the result of increased substrate concentrations (1). However, if a high influx
of amino acids continues, the organism synthesizes more of many
of the rate-limiting amino acid-degrading enzymes found in
liver. Prominent among these inductions are serine-threonine

Table II. Effects of Dietary Protein on Muscle Intracellular
Leucine Concentrations and Intracellular Muscle/Plasma
Leucine Ratios before or after the Meal
Intracellular leucine
concentration*

Muscle/plasma leucine

Casein

Before

After

Before

After

%

nmol/ml

nmol/ml

nmol/ml

nmol/ml

0
9
25
50

134±24*

106±16*
162±8*§

1.61±0.26*
1.25±0.31$

1.64±0.35$
1.02±0.13

300±17§
371±52§

1.00±0.12
1.02±0.14

0.95±0.03
0.70±0.07

94±10*
128±24*
244±53

Casein diets were fed for 10 d and values listed are from before or
three hours after presentation of the meal. Plasma and muscle leucine
concentrations were determined as described in Methods. Values are
means±SEM for 5 rats per group.
* Intracellular concentrations of leucine were calculated according to
the formula: intracellular [leucine] = nmol leucine/g muscle
- (0.2Xnmol leucine/ml plasma)/0.6.
* Significantly different (P < 0.05) from values in column without f.
P < 0.05 compared with before-meal values.
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Figure 4. Effects of single meals of varying
protein content on muscle BCKAD and
plasma concentration of leucine. Rats
were meal-fed a diet containing adequate
amounts of protein (25% casein) for 2
wk, then killed before or 3, 6, or 12 h after presentation of meals containing 9, 25,
or 50% casein. Food was withdrawn 3 h
after presentation. All postprandial rats
had food in their stomachs after 3 h and
no difference in food intake was observed
(14±1 g consumed; n = 15 rats). Muscle
BCKAD activity (A) and plasma leucine
concentrations (B) were measured as described in Methods. Values represent
means±SEM for 4-5 rats per group.
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dehydratase, histidase, tryptophan pyrrolase, tyrosine-a-ketoglutarate aminotransferase, glutamate-oxaloacetate and glutamate-pyruvate aminotransferases, and all the urea cycle enzymes
(reviewed in 1, 2, 40, 41). Hence, excesses of amino acids are
catabolized and in the process, essential precursors for gluconeogenesis, i.e., pyruvate and tricarboxylic acid cycle intermediates, are formed. A similar control mechanism for BCAA is
believed to be absent (1). Reports of BCAA aminotransferase
induction by diet are inconsistent and the observed effects are
relatively small compared to other amino acid-degrading enzymes (1, 13). Yet, BCAA oxidation in vivo is increased markedly
after high-protein feeding (5, 7, 8). In rats adapted to a highprotein diet, the protein content of the body does not increase,
and BCAA excretion in urine and feces is negligible (2). Based
on these considerations, Harper and coworkers (13, 30) calculated that when rats are switched from a 20 to 50% protein diet,
12,000 umol BCAA are available for degradation, whereas the
increase of BCAA in bodily fluids is only 100 Mmol. Hence,
extensive oxidation of BCAA must be occurring. In the present
study, a small increase in total BCKAD activity per milligram
DNA was observed in rats after feeding a high-protein diet for
2 wk. This may represent stimulation of enzyme synthesis and/
or decreased degradation of the complex. However, the major
effect of protein intake was exerted at the level of enzyme activation.
BCKAD activity is thought to be the major regulator of
BCAA oxidation in vivo (14). As liver BCKAD is fully active
in normally fed rats (13, 17-19), activation of extrahepatic
BCKAD would be expected to result in enhanced oxidation of
BCAA in vivo. In the present study, skeletal muscle BCKAD
was only 1-2% active during the postabsorptive period in rats
fed 25% casein (Figs. 3 A and 4 A). Increasing the casein content
of the diet from 25 to 50% for 10 d resulted in a greater than
three-fold increase in the percentage of active muscle BCKAD
measured either before or 3 h after feeding (Fig. 3 A). Furthermore, compared with postabsorptive values, consumption of
the 25 or 50% casein diet resulted in a greater than seven-fold
activation of muscle BCKAD. The proportion of BCKAD in
the active form rose from 2% in postabsorptive rats fed adequate
amounts of protein to > 40% in rats 3 h after consuming a highprotein diet. That a single normal or high-protein meal could
also activate muscle BCKAD is shown in Fig. 4 A; the duration
and magnitude of activation was proportional to the protein
content of the diet.
-
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Considering all available data, we observed a strong correlation between circulating leucine and the activity of muscle
BCKAD. Inspection of the points in Fig. 5 suggests that a
threshold phenomenon exists at leucine concentrations < 0.2
mM with a fairly steep slope for activation of muscle BCKAD
at leucine concentrations > 0.2 mM. At low circulating leucine
concentrations, liver may therefore assume greater importance
in BCAA homeostasis, but as circulating BCAA and muscle
BCKAD activity increase the latter may become the predominant
tissue in BCAA metabolism. The correlation between plasma
leucine and muscle BCKAD activity (21) is most simply explained by inhibition of BCKAD kinase by a-ketoisocaproate
(12), the transamination product of leucine. In studies of rats it
was found that the concentrations of BCKA in muscle paralleled
those of the BCAA in rats fed low, normal, or high-protein diets
(42), and plasma a-KIC was found to increase in man after a
protein meal (43). It is clear however that this simple explanation
for the relationship between muscle BKCAD and plasma leucine
is inadequate. Despite similar circulating leucine concentrations,
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Figure 5. Relationship of skeletal muscle BCKAD activity to the concentration of circulating leucine. Values from the chronic (closed circles) and acute (open circles) protein studies were taken from Figs. 3
and 4 respectively. The curve shown was calculated from the best linear least squares fit, which was obtained after semilog transformation
of the data (i.e., log % active complex vs. plasma leucine) and yielded
a linear correlation coefficient of 0.848 (P < 0.001; n = 107). Analysis
of the nontransformed data by linear regression yielded a correlation
coefficient of 0.788 (P < 0.001; n = 107).
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Figure 6. Leucine-mediated activation of muscle BCKAD
isolated from rats fed adequate or low protein diets. Rats
2 wk. After
were fed a 9 or 25% casein diet ad libitum for
an overnight fast, rats were infused with saline or 10, 25, 50,
or 100 Ismol L-leucine per 100 g body weight via the tail
vein. Rats were killed 15 min after infusion and the percentage of BCKAD in the active state (A) and plasma BCAA concentrations (B, 25% casein, and C, 9% casein) were measured
as described in Methods. Values represent means±SEM for 4
rats per group. BCKAD activation in response to leucine was
significantly depressed in rats fed the low-protein diet (P
< 0.01 by t test after injection of 50 or 100 umol leucine/100
g; P < 0.001, by comparison of the slopes of the linear regression lines for leucine dose vs. BCKAD activity).
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muscle BCKAD in rats fed a 9% protein diet activated less than
BCKAD from rats fed a 25% protein diet (Fig. 6). Futhermore,
meal-induced activation of BCKAD was greater than that observed after leucine infusions achieving similar plasma leucine
concentrations (compare Figs. 4 and 6). The two studies are not
directly comparable however because the duration of hyperleu-

before sacrifice was much longer in the former experiments. It is also noteworthy that the postprandial activation of
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2.5 times

greater in rats maintained on a high-protein diet than in those
maintained on a normal diet although plasma leucine was only
50% higher in the former group after consumption of the protein
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meal (compare Figs. 3 and 4). It seems unlikely that meal-induced insulin release played a role in the postprandial activation
of BCKAD, as treating postabsorptive rats with large doses of
insulin and glucose did not activate the complex in muscle (31).
Furthermore, in perfused hindlimbs of postabsorptive rats,
insulin added to the perfusate decreased flux through
BCKAD (44).
Despite a marked activation of muscle BCKAD in rats fed
a high protein diet, plasma and tissue concentrations of BCAA
remained elevated (Figs. 3 and 4, Table II). The BCAA aminotransferase reaction is readily reversible and indeed 80-90%
of leucine transaminated to a-ketoisocaproate is reaminated to
leucine in humans in vivo (14). High levels of tissue glutamate
in animals fed high-protein diets would favor maintenance of
elevated BCAA by restraining their transamination and favoring
reamination of BCKA (I13, 45). The physiological advantage of
maintaining enlarged BCAA pools during high-protein feeding
is unknown. Elevated BCAA concentrations in blood could act
as a protective buffer, competing with other large neutral amino
acids (e.g., tyrosine, tryptophan, and phenylalanine) for transport
across the blood-brain barrier (3, 46), thus preventing increased
synthesis of certain neurotransmitters (47, 48). The toxic effects
of elevated brain aromatic amino acids are well documented
(49). BCAA have been used clinically to reduce the levels of
brain aromatic amino acids in hepatic encephalopathy (10) and

phenylketonuria (50).
Consumption of protein-deficient diets results in inactivation
of liver BCKAD (17, 19, 20, 39). Recently, increased BCKAD
kinase activity was reported in livers and hearts of rats fed a
protein-free diet (51). The decrease in the percentage of active
complex in livers of rats fed low-protein diets presumably represents a mechanism by which essential BCAA are conserved
during periods of protein depletion. Indeed, BCAA oxidation is
severely depressed in man and rat after low-protein feeding (5,
7, 52-55). In the present study, switching from an adequate to
a low-protein diet for 10 d had no significant effect on muscle
BCKAD activity in the postabsorptive state (Fig. 3 A). This is
not surprising as most of the complex was already in an inactive
form in postabsorptive rats fed the adequate protein diet (i.e.,
2% active). However, the following observations were of interest:
(a) muscle BCKAD from rats fed protein-free or low-protein
diets required a longer period of preincubation with Mg2e to
attain maximal activity than BCKAD from rats fed adequate
protein diets (Fig. 2), and (b) plasma leucine concentrations increased approximately two-fold after consumption of the lowprotein diet, but muscle BCKAD activity remained unchanged
(Fig. 3). To further investigate these differences, varying amounts
of leucine were infused into rats fed adequate or low-protein
diets. Despite similar circulating leucine concentrations, the
complex from rats fed the low-protein diet was less responsive
to leucine activation than the enzyme isolated from rats given
adequate amounts of protein (Fig. 6). The refractoriness of muscle BCKAD to activation in rats fed low-protein diets may be
of physiological significance. An activation-resistant complex in
muscle from low-protein-fed rats, along with an inactivated
complex in liver, would ensure efficient conservation of BCAA
during periods of protein depletion. The mechanism of this resistance is not clear. In view of the findings of Espinal et al. (51),
increased skeletal muscle BCKAD kinase activity in response
depletion is an attractive hypothesis.
We have no explanation for the increased basal BCKAD
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activity observed in postabsorptive rats maintained on the protein-free diet (Fig. 3). These animals were in a protein-catabolic
state, but intracellular leucine concentrations were not significantly different from the values in the 9 and 25% casein groups
(Table II). The apparent increase in the muscle/plasma leucine
ratio in this group (Table II) may be a reflection of accelerated
net degradation of muscle protein. a-Ketoisocaproate is compartmentalized in muscle cells (56); whether intramitochondrial
a-ketoisocaproate is increased in muscles of protein-starved rats
or if other mechanisms lead to the relatively modest activation
of the complex in the postabsorptive state is not known.
Our studies were carried out in rats trained to consume their
daily caloric requirements during a relatively short period of
time. Because rats are predominantly nocturnal "nibblers" rather
than "meal eaters," the postprandial activation of BCKAD may
be less marked when normal feeding patterns are maintained.
In rats fed a normal diet ad libitum the plasma leucine concentration cycles between a nadir of 170 uM at 6:00 p.m. and a
peak of 275 jM at 6:00 a.m. (57). Man however is a meal eater;
following a protein meal most of the absorbed amino acids (except for the BCAA) are taken up by the liver, while a large fraction
of BCAA is taken up by muscle (58). Because BCAA concentrations in muscle generally parallel plasma concentrations (reviewed in 13) and the latter increase two- to three-fold after a
protein meal in man (7, 43, 58), muscle BCKAD may be activated and likely contributes to the postprandial increase in BCAA
oxidation (7). Our studies in rats may have practical implications
for nutritional therapy in some patients. Distribution or presentation of dietary protein in a manner to avoid large increases in
circulating BCAA, or slowing the rate and extending the duration
of amino acid infusions, may prevent or decrease activation of
muscle BCKAD and spare BCAA for protein synthesis.
Our data support an active role for skeletal muscle in the
disposal and conservation of BCAA. Muscle releases BCKA to
the blood stream for eventual uptake and oxidation by the liver
(13, 24). In addition, during periods of protein surfeit, the capacity to oxidize BCAA carbon increases markedly in skeletal
muscle, whereas during periods of protein inadequacy, skeletal
muscle, along with liver, adapts to conserve essential BCAA.
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